Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
My Portfolio
Anaptysbio Inc
(NQ:
ANAB
)
25.98
USD
-0.50 (-1.89%)
Official Closing Price
Updated: 7:28 PM EST, Feb 25, 2021
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
376,700
Open
26.66
Bid (Size)
25.58 (4)
Ask (Size)
30.50 (2)
Prev. Close
26.48
Today's Range
25.16 - 27.34
52wk Range
12.06 - 35.85
Shares Outstanding
23,497,680
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
Top News
More News
AnaptysBio Announces Fourth Quarter and Full Year 2020 Financial Results and Provides Pipeline Updates
Today 16:05 EST
From
GlobeNewswire News Releases
TransCode Therapeutics Announces Key Appointments
February 18, 2021
TransCode Therapeutics today announced that it has recently elected a Chairman of its Board of Directors, appointed two new Independent Directors to the Board, and appointed a new member to its...
From
Business Wire News Releases
Performance
YTD
+11.22%
+11.22%
1 Month
+6.39%
+6.39%
3 Month
+0.74%
+0.74%
6 Month
+54.46%
+54.46%
1 Year
+64.43%
+64.43%
More News
Read More
AnaptysBio to Present at the 39th Annual J.P. Morgan Healthcare Conference
January 07, 2021
From
GlobeNewswire News Releases
AnaptysBio to Present at the 2020 Jefferies London Virtual Healthcare Conference
November 13, 2020
From
GlobeNewswire News Releases
AnaptysBio Announces Third Quarter 2020 Financial Results and Provides Pipeline Updates
November 04, 2020
From
GlobeNewswire News Releases
AnaptysBio and GlaxoSmithKline Amend Strategic Immuno-Oncology Collaboration
October 26, 2020
From
GlobeNewswire News Releases
Why AnaptysBio Fell by as Much as 10% Today
February 23, 2021
Tags
Market News
ANAB
JPM
From
Motley Fool
Why ESSA Pharma, AnaptysBio And More Are Moving Today
February 11, 2021
Tags
Movers
Market News
Benzinga
From
Benzinga
AnaptysBio Clears Key Benchmark, Hitting 80-Plus RS Rating
February 16, 2021
From
Investor's Business Daily
10 Biggest Price Target Changes For Thursday
February 11, 2021
Tags
AVLR
ANAB
Benzinga
From
Benzinga
Stocks Generating Improved Relative Strength: AnaptysBio
February 12, 2021
From
Investor's Business Daily
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.